Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV: Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord. 2009, 117 (Suppl 1): S1-S2.
Article
PubMed
Google Scholar
Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV, Canadian Network for Mood and Anxiety Treatments (CANMAT): Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord. 2009, 117 (Suppl 1): S5-14.
Article
PubMed
Google Scholar
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011, 21: 655-679. 10.1016/j.euroneuro.2011.07.018.
Article
CAS
PubMed
Google Scholar
Moller HJ, Bitter I, Bobes J, Fountoulakis K, Hoschl C, Kasper S: Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression. Eur Psychiatry. 2012, 27: 114-128. 10.1016/j.eurpsy.2011.08.002.
Article
PubMed
Google Scholar
Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV, Canadian Network for Mood and Anxiety Treatments (CANMAT): Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009, 117 (Suppl 1): S26-S43.
Article
PubMed
Google Scholar
Moller HJ: Are placebo-controlled studies required in order to prove efficacy of antidepressants?. World J Biol Psychiatry. 2005, 6: 130-131. 10.1080/15622970510030108.
Article
PubMed
Google Scholar
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn't. BMJ. 1996, 312: 71-72. 10.1136/bmj.312.7023.71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hegerl U, Allgaier AK, Henkel V, Mergl R: Can effects of antidepressants in patients with mild depression be considered as clinically significant?. J Affect Disord. 2012, 138: 183-191. 10.1016/j.jad.2011.05.015.
Article
CAS
PubMed
Google Scholar
Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL: Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry. 2010, 71: 270-279. 10.4088/JCP.08r04516blu.
Article
CAS
PubMed
Google Scholar
Rutherford BR, Sneed JR, Roose SP: Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom. 2009, 78: 172-181. 10.1159/000209348.
Article
PubMed
PubMed Central
Google Scholar
Papakostas GI, Fava M: Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol. 2009, 19: 34-40. 10.1016/j.euroneuro.2008.08.009.
Article
CAS
PubMed
Google Scholar
Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schunemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD: Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. 2011, MR000012, 4
Book
Google Scholar
Parker G: Antidepressants on trial: how valid is the evidence?. Br J Psychiatry. 2009, 194: 1-3. 10.1192/bjp.bp.108.054767.
Article
PubMed
Google Scholar
Seemuller F, Moller HJ, Obermeier M, Adli M, Bauer M, Kronmuller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, Riedel M: Do efficacy and effectiveness samples differ in antidepressant treatment outcome? an analysis of eligibility criteria in randomized controlled trials. J Clin Psychiatry. 2010, 71: 1425-1433. 10.4088/JCP.09m05166blu.
Article
PubMed
Google Scholar
Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH: Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009, 166: 599-607. 10.1176/appi.ajp.2008.08071027.
Article
PubMed
Google Scholar
Jones R, Jones RO, McCowan C, Montgomery AA, Fahey T: The external validity of published randomized controlled trials in primary care. BMC Fam Pract. 2009, 10: 5-10.1186/1471-2296-10-5.
Article
PubMed
PubMed Central
Google Scholar
Gross CP, Mallory R, Heiat A, Krumholz HM: Reporting the recruitment process in clinical trials: who are these patients and how did they get there?. Ann Intern Med. 2002, 137: 10-16.
Article
PubMed
Google Scholar
Largent EA, Joffe S, Miller FG: Can research and care be ethically integrated?. Hastings Cent Rep. 2011, 41: 37-46.
Article
PubMed
Google Scholar
Loh A, Simon D, Wills CE, Kriston L, Niebling W, Harter M: The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns. 2007, 67: 324-332. 10.1016/j.pec.2007.03.023.
Article
PubMed
Google Scholar
Drake RE, Cimpean D, Torrey WC: Shared decision making in mental health: prospects for personalized medicine. Dialogues Clin Neurosci. 2009, 11: 455-463.
PubMed
PubMed Central
Google Scholar
Brody H, Colloca L, Miller FG: The placebo phenomenon: implications for the ethics of shared decision-making. J Gen Intern Med. 2012, 27: 739-742. 10.1007/s11606-011-1977-1.
Article
PubMed
PubMed Central
Google Scholar
Colloca L, Miller FG: Role of expectations in health. Curr Opin Psychiatry. 2011, 24: 149-155. 10.1097/YCO.0b013e328343803b.
Article
PubMed
Google Scholar
Hegerl U, Mergl R: The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. J Psychopharmacol. 2010, 24: 445-448. 10.1177/0269881109106930.
Article
CAS
PubMed
Google Scholar
Moller HJ, Maier W: Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci. 2010, 260: 25-39. 10.1007/s00406-009-0070-9.
Article
PubMed
Google Scholar
Hrobjartsson A, Kaptchuk TJ, Miller FG: Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol. 2011, 64: 1223-1229. 10.1016/j.jclinepi.2011.01.008.
Article
PubMed
PubMed Central
Google Scholar
Colloca L, Lopiano L, Lanotte M, Benedetti F: Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004, 3: 679-684. 10.1016/S1474-4422(04)00908-1.
Article
PubMed
Google Scholar
Brody H, Miller FG: Lessons from recent research about the placebo effect--from art to science. JAMA. 2011, 306: 2612-2613. 10.1001/jama.2011.1850.
Article
CAS
PubMed
Google Scholar
Posternak MA, Zimmerman M: Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. Br J Psychiatry. 2007, 190: 287-292. 10.1192/bjp.bp.106.028555.
Article
PubMed
Google Scholar
Miller FG, Colloca L: The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth. 2011, 32: 229-243. 10.1007/s11017-011-9179-8.
Article
PubMed
Google Scholar
Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M: Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry. 2004, 65: 1174-1179. 10.4088/JCP.v65n0904.
Article
PubMed
Google Scholar
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C: Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009, 373: 746-758. 10.1016/S0140-6736(09)60046-5.
Article
CAS
PubMed
Google Scholar
Cipriani A, Furukawa TA, Geddes JR, Malvini L, Signoretti A, McGuire H, Churchill R, Nakagawa A, Barbui C, MANGA Study Group: Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. J Clin Psychiatry. 2008, 69: 1732-1742. 10.4088/JCP.v69n1108.
Article
PubMed
Google Scholar
Severus E, Lipkovich I, Seemuller F, Obermeier M, Grunze H, Bernhard B, Dittmann S, Riedel M, Möller HJ: The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice. World J Biol Psychiatry.
Wechsler ME, Kelley JM, Boyd IO, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ: Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 2011, 365: 119-126. 10.1056/NEJMoa1103319.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moerman DE: Meaningful placebos--controlling the uncontrollable. N Engl J Med. 2011, 365: 171-172. 10.1056/NEJMe1104010.
Article
CAS
PubMed
Google Scholar